THE CELL CODING COMPANY
DEAD

Serial Number

88901754

Owner

Bit Bio Limited

Attorney

Katrina G. Hull

Filing Date

May 5, 2020

Add to watchlist:

No watchlists yet
View on USPTO

THE CELL CODING COMPANY Trademark

Serial Number: 88901754

THE CELL CODING COMPANY is a trademark filed by Bit Bio Limited on May 5, 2020. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 9 (Computers & Electronics), Class 40 (Treatment & Processing), Class 42 (Computer & Scientific), Class 29 (Meats & Processed Foods). The application is currently no longer active.

Owner Contact Info

Bit Bio Limited (21 trademarks)

Pioneer House,
Cambridge, Cambridgeshire CB24 9NL , GB

Entity Type: 99

Trademark Details

Filing Date

May 5, 2020

Registration Date

Not Registered

Goods & Services

Custom manufacture of biopharmaceuticals; processing of biopharmaceutical materials for others; custom manufacture of stem cells for research purposes, stem cells for scientific purposes, stem cells other than for medical or veterinary purposes, skeletal myocytes for research purposes, cortical neurons for research purposes, biological tissue for research and scientific purposes, biological tissue cultures other than for medical or veterinary purposes, cultures of cell media other than for medical or veterinary use, chemical reagents for use in biotechnology, other than for medical or veterinary use, nutritive agents for processing living cells other than for medical use, semi-processed natural proteins for manufacturing food, proteins for use in the manufacture of food products, proteins for use in recombinant DNA technology other than for medical use, cell therapeutics, genetically or otherwise modified cells, cells which are propagated, cultivated and expanded in bioreactors, cells for the purpose of tissue regeneration, living cells for medical use, cells for medical use, biological preparations for medical use, diagnostic preparations for medical and/or veterinary purposes, cell preparations for drug screening, cell preparations for genetic testing, screening, stem cells for medical purposes, stem cells for veterinary purposes, cell growth media, tissue culture media, cytokines, antibodies, and reagents for medical, medical research or diagnostic use, tissue culture media, growth factors, growth media and serum for in vitro culturing, development, maintenance, expansion, assay or manipulation of cells, cell separation reagents, magnetic cell separation equipment, meat, meat substitutes, tissue engineered meat, synthetic meat, cultured meat, laboratory-grown meat and fish, not live

Downloadable and recorded computer software and computer hardware for the separation of biological and non-biological materials; downloadable and recorded bioinformatics software for collection of information on biological materials; downloadable and recorded software for the control of laboratory robots; downloadable and recorded software program for medical, clinical, research and biomanufacturing purposes, namely, downloadable and recorded software for conducting medical and clinical research and control laboratory manufacturing robots; bioreactors for biomanufacturing; bioreactors for research use; bioreactor for cell culturing; bioreactors for laboratory use; downloadable and recorded computer-aided manufacturing software for the separation of biological and non-biological materials; smart manufacturing system controls for laboratory robots and laboratory automation equipment featuring downloadable software incorporating algorithms to control laboratory robots and laboratory automation equipment; electronic control units for laboratory robots and laboratory automation equipment featuring downloadable software incorporating algorithms to control laboratory robots and laboratory automation equipment; laboratory apparatus for magnetic cell separation, namely, apparatus for the separation of cell populations for medical or clinical use

Meat; meat substitutes; tissue engineered meat; synthetic meat; cultured meat; laboratory-grown meat; fish, not live

Pharmaceuticals in the nature of cell therapeutics for medical, therapeutic or clinical use; genetically or otherwise modified cells for medical or clinical use; cells which are propagated, cultivated and expanded in bioreactors for medical or clinical use; cells for the purpose of tissue regeneration for medical or clinical use; living cells for medical use; cells for medical use; diagnostic preparations for medical and veterinary purposes; cell preparations for medical use in drug screening regeneration; cell preparations for genetic testing and screening for medical purposes or clinical use; stem cells for medical purposes; stem cells for veterinary purposes; cell growth media for growing cells, tissue culture media, cytokines, antibodies, and reagents for medical, and diagnostic or clinical use; tissue culture media growth factors in the nature of cell growth and growth media for in vitro culturing, development, maintenance, expansion, assay or manipulation of cells all for medical and clinical use; cell separation reagents for medical and clinical use

Stem cells for research purposes; stem cells for scientific purposes; stem cells other than for medical or veterinary purposes; skeletal myocytes for research purposes; cortical neurons for research purposes; biological human tissue for research and scientific purposes; biological tissue cultures other than for medical or veterinary purposes; cultures of cell media for scientific and research use; chemical reagents for use in biotechnology, other than for medical or veterinary use; nutritive agents for processing living cells other than for medical use; semi-processed natural proteins for manufacturing food; proteins for use in the manufacture of food products; proteins for use in recombinant DNA technology other than for medical use

Biotechnology research; scientific testing for others in the area of biotechnology for research, clinical, therapeutic and manufacturing purposes; stem cell research; synthetic biology services, namely, biological research; stem cell biology services, namely, biological research; scientific services for scientific, research, clinical, therapeutic and manufacturing purposes relating to the isolation and cultivation of human tissues and cells; research and development in the field of microorganisms and cells; research and development in relation to genetic testing, screening; research and development in relation to drug screening; cell separation technology services for scientific, research, clinical, therapeutic and manufacturing purposes; cell separation research services; consultancy relating to biotechnology; scientific and research consultancy relating to drug screening; scientific and research consultancy relating to genetic screening; scientific and research consultancy relating to cell therapy; laboratory research in the field of drug discovery, cell therapy, stem cells, microorganisms, human tissues, synthetic biology and biomanufacturing; research on food; research and development in the field of animal cells cultivated within bioreactors; research in the reduction of carbon emissions; Development and testing of computing methods, software algorithms and software for medical, clinical, research and biomanufacturing purposes

Filing History

ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Aug 19, 2021 MAB2
ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Aug 19, 2021 ABN2
NOTIFICATION OF FINAL REFUSAL EMAILED
Feb 5, 2021 GNFN
FINAL REFUSAL E-MAILED
Feb 5, 2021 GNFR
FINAL REFUSAL WRITTEN
Feb 5, 2021 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Jan 29, 2021 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jan 28, 2021 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jan 28, 2021 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Aug 3, 2020 GNRN
NON-FINAL ACTION E-MAILED
Aug 3, 2020 GNRT
NON-FINAL ACTION WRITTEN
Aug 3, 2020 CNRT
ASSIGNED TO EXAMINER
Jul 30, 2020 DOCK
PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
May 21, 2020 AMPX
ASSIGNED TO LIE
May 20, 2020 ALIE
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
May 16, 2020 NWOS
TEAS VOLUNTARY AMENDMENT RECEIVED
May 14, 2020 PARI
NEW APPLICATION ENTERED
May 8, 2020 NWAP